Connectors Cracking: A Root Cause Analysis and Material Selection Effort
Solutions
Failure Analysis & CAPA
Materials
Industries
Medical Devices; Combination Products; Drug Products, Personal Care Products

Challenge

A medical device manufacturer faced a growing number of field complaints involving cracked connectors during device use and storage. The component, originally molded from Acrylonitrile Butadiene Styrene (ABS) polymer was exhibiting environmental stress cracking (ESC), leading to potential sterility breaches and clinical usability issues. The failures were sporadic and not evident during standard in-process quality control, making the issue difficult to isolate

Chemva’s Solution

Chemva launched a structured root cause investigation, beginning with a systematic review of all possible chemical, mechanical, and environmental exposures the connectors could experience from manufacturing through clinical use.
Our review considered:

  • Residual stress from molding
  • Reviewing list of all potential chemicals/formulations interacting with the ABS part
  • Mechanical loads from connections and torquing

We then designed custom benchtop experiments, exposing ABS parts to combinations of stress and chemical agents that mimicked real-world scenarios. Under this simulated environment, cracking consistently occurred under a certain stress level, confirming ESC from isopropyl alcohol exposure as the root cause.Through iterative mechanical testing and compatibility assessments, rigid polyurethane emerged as the optimal replacement, balancing strength, moldability, biocompatibility, and resistance to cracking under alcohol exposure.

Impact Delivered

Chemva’s systematic approach not only resolved the cracking issue but also enhanced the product’s long-term reliability and manufacturability. By selecting a validated alternative material, the partner prevented further field failures, avoided a costly recall, and achieved regulatory acceptance for the material change with minimal disruption. The improved connector has now been in the field for over two years with zero reported failures.

More Case Studies
More Case Studies That Reflect Your Area of Interest
Explore additional case studies that address similar challenges, industries, or technical domains — and see how Chemva’s expertise translates across different projects.
Toxicology Risk Assessment
Establishing Toxicological/Biological Equivalence After Undisclosed Additive Change in Medical-Grade Resin
Chemva recommended a dual Toxicological Risk Assessment (TRA) strategy, using results from E&L testing
Toxicology Risk Assessment
Extractables / Leachables (E/L)
In-Silico Genotoxicity Assessment for Drug Packaging-Related Impurities
Chemva performed a tiered in-silico genotoxicity assessment using (Q)SAR tools and expert toxicological interpretation to classify the packaging-derived impurities per ICH M7 guidelines.
Toxicology Risk Assessment
Biocompatibility
Addressing Carcinogenicity Concerns Without E&L for EU MDR Submission
Chemva proposed and executed a paper-based Material Risk Assessment (MRA) specifically designed to address both genotoxic and non-genotoxic carcinogenicity pathways.
Chemical Characterization
Assessing the Impact of Antioxidant Reduction in a Container Closure System
Chemva performed a comprehensive risk assessment focused on understanding whether the antioxidant reduction would materially impact the polymer’s performance, stability, or toxicological profile.
Chemical Characterization
Biocompatibility
Resolving Unknown Extractables to Enable Pivotal Clinical Study
Chemva swiftly conducted a comprehensive Material Risk Assessment
Biocompatibility
Material Science
Defending Polymer Stability with Historical Use and Material Science
Chemva led a detailed material-specific risk assessment, supported by both scientific literature and historical clinical use.
Toxicology Risk Assessment
Avoiding Simulated E&L Testing Through Read-Across Toxicological Risk Assessment
Chemva conducted a comprehensive Toxicological Risk Assessment (TRA) using a read-across strategy, allowing us to bridge data gaps with scientifically valid surrogate information.
Chemical Characterization
Biocompatibility
Reverse Engineering Competitor Device Materials and Surface Coatings
Chemva designed and executed a custom reverse engineering plan targeting both bulk materials and surface coatings of the competitor’s connector and delivery components.
Chemical Characterization
Material Science
Biocompatibility
Establishing Material Equivalence After a Raw Material Supplier Manufacturing Site Change
Chemva conducted a comprehensive material equivalency assessment to evaluate potential variations between batches sourced from the original and new manufacturing sites.
Chemical Characterization
Toxicology Risk Assessment
Identifying Formaldehyde Risk Through Material Risk Assessment for a Medical Device
Chemva conducted a systematic, material-specific MRA, analyzing each component and processing additive and manufacturing steps to identify chemical structures or precursors associated with CoCs.
Material Science
Biocompatibility
Custom Formulating a Non-PTFE Lubricious Coating to Solve Supply Chain Constraints & Incoming Regulations
Leveraging our deep expertise in biocompatible coatings and polymer systems, Chemva led a coating reformulation and optimization program tailored to the device’s surface, application method, and clinical use.
Material Science
Material Compatibility Assessment for Solvent-Bonded Luer Hub Assembly
Chemva led a material compatibility evaluation using HansenSolubility Parameters (HSP) to scientifically assess the interaction potentialbetween each candidate hub material, the bonding solvent, and the polyurethanetubing.
Extractables / Leachables (E/L)
Biocompatibility
Toxicology Risk Assessment
Identifying Critical Gaps with E&L Protocol to Ensure Seamless PMA Application
Chemva conducted a comprehensive review of the E&L protocol, evaluating analytical strategies, extraction conditions, and toxicological relevance.
Material Science
Extractables / Leachables (E/L)
Virtual Project Management
Proactive Semi-Targeted E&L Strategy for a Polymer-Additive-Based Medical Device
Chemva’s semi-targeted E&L design eliminated potential FDA objections before they could be raised.
Material Science
Virtual Project Management
Securing Product Integrity with Reliable Raw Materials Supply
Chemva developed and implemented a risk-based supplier qualification framework
Biocompatibility
Biological Evaluation Plan (BEP) for a Next-Generation Implantable Device
Developed a risk-based BEP to meet FDA and ISO 10993-1 standards, helping the client avoid delays and save $300K through targeted testing.
Failure Analysis & CAPA
Materials
Connectors Cracking: A Root Cause Analysis and Material Selection Effort
Chemva’s systematic approach not only resolved the cracking issue but also enhanced the product’s long-term reliability and manufacturability.
Biocompatibility
Overcoming Adverse Sensitization Results
Chemva led a contextual data evaluation to assess whether the positive result represented a real clinical risk.
Biocompatibility
When Failed Cytotoxicity Is Not the Whole Story
Chemva’s strategic data interpretation helped the partner avoid unnecessary re-testing and product reformulation
Material Science
Extractables / Leachables (E/L)
Strategic Vendor Selection for Biocompatible Polymers in Inhaler Development
Chemva implemented a multi-step vendor qualification strategy to identify a reliable source of medical-grade polymer materials.
Consulting. Collaborating. Catalyzing.
Accelerating innovation through expert solutions, teamwork, and education.